skip to Main Content
MedMen Plunges After Scrapping PharmaCann Merger; Marijuana Stocks Slide

California-based marijuana retailer MedMen (OTC:MMNFF) on Tuesday said it would terminate its merger with PharmaCann and appointed a new CFO, killing off a deal that would have made it one of the biggest cannabis companies in the U.S. MedMen stock plummeted, while Canadian marijuana stocks reclaimed gains.

The announcement came a little less than a month after MedMen said the deal cleared a regulatory hurdle that moved the transaction closer to completion. The merger had been expected to close at the end of the year.

MedMen was not immediately available for comment. The company reports fourth-quarter results on Oct. 28.

MedMen also named Zeeshan Hyder as its new CFO, effective immediately, representing the latest turnover at the top, amid concerns about the company’s spending habits. The cannabis retailer said it terminated Michael Kramer, who had served at that post, on Monday.

Regulations Cited In MedMen-PharmaCann Termination

MedMen cited several reasons for the decision to scrap the $682 million all-stock deal for Chicago-based PharmaCann, announced last year.

For one, the company cited a slide in marijuana stocks broadly, as the industry struggles to live up to sales and profit expectations. PharmaCann shareholders would have received 186.4 million shares of the combined company.

MedMen added that PharmaCann’s cultivation and manufacturing business required “significant capital expenditures.” [Read More @]


This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Senate Democrats Remove Spending Bill Provision That Blocked D.C. From Legalizing Marijuana Sales

A package of spending bills unveiled by a U.S. Senate committee on Monday evening does not include language that had prohibited D.C. from legalizing the sale of marijuana for the last six years, lifting a significant roadblock to the city’s plans to legalize and license dispensaries to sell the drug for recreational use. Earlier this summer the House of…

Alabama Medical Cannabis Commission: No marijuana licenses before 2022

An Alabama regulatory commission has plenty to do before people can apply for medical cannabis licenses, so it won’t push for a date that might allow sales next year, a commission official said. The Alabama Medical Cannabis Commission had said earlier that it might ask for the date to be moved up. It decided last week not to do…

Panel may scrap South Dakota medical marijuana program for outright legalization

South Dakota’s new medical marijuana law could be scrapped and replaced with what’s being called a “compromise” that would legalize cannabis use for adults. That’s the aim of draft legislation that will be considered Tuesday by a committee that spent the summer and fall studying “adult-use” marijuana policy. “It’s about as close as we’re going to…

Unrivaled Brands’ Frank Kneuttel is Turning the MSO Gameplan On Its Head

Watching Santa Ana, California-based Unrivaled Brands (OTCQX: UNRV) compete in this market reminds me of the movie Memento, where memoryless Guy Pearce literally experiences the action unfold along with the rest of us, even though it’s his story and he’s the only one in it living life essentially in reverse. Similarly, and this may indeed…

More Categories

Back To Top
×Close search